Skip to main content

Table 1 Comparison of training and validation set data

From: A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers

Variables

Training set

(n = 350)

Validation set

(n = 150)

P

OP (%)

124 (35.4%)

60 (40%)

0.331

Female (%)

258 (73.7%)

112 (74.7%)

0.824

Age (years)

64 (57, 70)

64 (57, 71)

0.750

RA duration (years)

9 (4, 16)

9 (4, 14)

0.795

25 (OH)D (nmol/L)

38.9 (28.6, 52.7)

40.9 (26.5, 55.1)

0.447

β-CTX (pg/mL)

273 (190, 339)

290 (200, 340)

0.402

OC (ng/mL)

13.3 (9.9, 18.8)

13.2 (9.1, 18.5)

0.79

PINP (ng/mL)

43.2 (32.4, 55.1)

41.9 (32.5, 55.6)

0.946

ACPA (U/mL)

249 (44, 514)

318 (35, 676)

0.645

RF (IU/mL)

70.1 (14.5, 288.5)

68.5 (14.2, 211.3)

0.863

ESR (mm/h)

44.5 (25.3, 66.0)

41.0 (24.0, 65.0)

0.584

CRP (mg/L)

9.55 (1.35, 26.45)

9.80 (2.07, 23.14)

0.605

TG (mmol/L)

4.40 (3.77, 5.06)

4.48 (3.96, 5.08)

0.482

TC (mmol/L)

1.04 (0.80, 1.44)

1.10 (0.85, 1.56)

0.213

HDL-C (mmol/L)

1.20 (0.97, 1.49)

1.19 (0.94, 1.43)

0.409

LDL-C (mmol/L)

2.60 (2.04, 3.37)

2.73 (2.04, 3.44)

0.502

  1. 25(OH)D: 25-hydroxy vitamin D; ACPA: anti-cyclic citrullinated peptide antibody; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; OC: osteocalcin; OP: osteoporosis; PINP: N-terminal propeptide of type I procollagen; RF: rheumatoid factor; TC: total cholesterol; TG: triglycerides; β-CTX: beta C-terminal cross-linked peptide